Crossmark

Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review

Crossref DOI link: https://doi.org/10.47176/mjiri.34.41

Published Online: 2020-10-30

Update policy: https://doi.org/10.47176/mjiri/crossmark_policy

Authors

Rezapour, Aziz

Alidoost, Saeide

Asgharzadeh, Asra

Farhadi, Zeynab

Khodadadi, Najme

Mohammadi Bakhsh, Roghayeh

Sepehrian, Razieh

Salemi, Morteza

Taheri Mirghaed, Masood

Behzadifar, Masoud

Sohrabi, Rahim